ReviewPhilosophical transactions. Series A, Mathematical, physical, and engineering sciences2025
Transitioning enzyme catalysis towards photocatalysis.
Review in Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The structural chemistry and biosynthesis of chlorophylls.RSC chemical biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Enzyme biocatalysis is being industrialized at a phenomenal rate. Biocatalysis offers routes to chemical transformations that avoid the use of expensive metal catalysts, high temperatures and pressures, while providing impressive enantio-, regio- and chemo-selectivities. Working individually or as cascades, in live cells or cell-free preparations, to manufacture everyday chemicals, materials, healthcare products, fuels and pharmaceuticals and in diagnostic and industrial sensing applications, enzymes are key enablers in a circular bioeconomy. An ability to exploit and tailor biocatalysts rapidly and predictably requires knowledge of structure-mechanism relationships and the physical chemistry of enzyme action. This knowledge has advanced since our millennium article on this topic (Sutcliffe and Scrutton
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.